4
Changes in Ownership
PDS Biotechnology Corp Filed Acc 0001127602-17-011763
Options or other derivatives
- Chief Medical Officer acquired 110,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Faleck Herbert J Chief Medical Officer | 2017-03-13 | Grant or award · Stock Option (right To Purchase) | +110,000 | $8.86 | $974,600 | 110,000 | D: show line 1 in the form |
Loading xslF345X03/form4.xml…